M D Aljurf

Summary

Affiliation: King Faisal Specialist Hospital and Research Centre
Country: Saudi Arabia

Publications

  1. doi request reprint Status of hematopoietic stem cell transplantation in the WHO Eastern Mediterranean Region (EMRO)
    Mahmoud Aljurf
    King Faisal Cancer Center, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia
    Transfus Apher Sci 42:169-75. 2010
  2. doi request reprint High efficacy and low toxicity of APL induction with concurrent idarubicin/ATRA followed by a novel and simplified outpatient post-remission therapy using single doses of idarubicin and intermittent ATRA
    M Aljurf
    King Faisal Cancer Centre, King Faisal Specialist Hospital and Research Centre, P O Box 3354, Riyadh, 11211, Saudi Arabia
    Med Oncol 27:702-7. 2010
  3. doi request reprint Standard treatment of acquired SAA in adult patients 18-40 years old with an HLA-identical sibling donor
    M Aljurf
    Adult HSCT Program, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia
    Bone Marrow Transplant 48:178-9. 2013
  4. pmc Hepatotoxicity induced by horse ATG and reversed by rabbit ATG: a case report
    Khalid A Al-Anazi
    Section of Adult Hematology and Hematopoietic Stem Cell Transplant, King Faisal Cancer Centre, King Faisal Specialist Hospital and Research Centre, P, O, Box 3354, Riyadh 11211, Saudi Arabia
    J Med Case Reports 1:35. 2007
  5. ncbi request reprint Successful treatment of steroid-refractory autoimmune thrombocytopenia associated with Castleman disease with anti-CD-20 antibody (rituximab)
    Khalid Ibrahim
    Section of Adult Hematology HSCT, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia
    Hematol Oncol Stem Cell Ther 4:100-2. 2011
  6. pmc Special issues related to hematopoietic SCT in the Eastern Mediterranean region and the first regional activity report
    M D Aljurf
    Adult HSCT, King Faisal Cancer Center, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia
    Bone Marrow Transplant 43:1-12. 2009
  7. ncbi request reprint Chemotherapy and hematopoietic stem cell transplantation for adult T-cell lymphoblastic lymphoma: current status and controversies
    Mahmoud Aljurf
    Section of Adult Hematology BMT, King Faisal Cancer Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia
    Biol Blood Marrow Transplant 11:739-54. 2005
  8. ncbi request reprint Antigen- and/or immune-driven lymphoproliferative disorders
    M D Aljurf
    Department of Oncology, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia
    Ann Oncol 14:1595-606. 2003
  9. pmc Autologous bone marrow transplanation for extramedullary plasmacytoma presenting as adrenal incidentaloma
    Mohammed Ahmed
    Departments of Medicine, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia
    Ann Saudi Med 29:219-22. 2009
  10. ncbi request reprint High efficacy and low toxicity of short-course oral valganciclovir as pre-emptive therapy for hematopoietic stem cell transplant cytomegalovirus infection
    A J M Saleh
    King Faisal Cancer Centre, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia
    Hematol Oncol Stem Cell Ther 3:116-20. 2010

Collaborators

  • Khalid F Tabbara
  • J R Passweg
  • Nasir Bakshi
  • Kamran Alimoghaddam
  • A Ibrahim
  • Mouhab Ayas
  • Mohammed Ahmed
  • M El Sayed Zaki
  • Dietger Niederwieser
  • F Locatelli
  • Jane Apperley
  • Khalid Ibrahim
  • A J M Saleh
  • Naeem Chaudhri
  • Cynthia Lehe
  • Khalid A Al-Anazi
  • Kate Cwynarski
  • Assem Elghazaly
  • Irfan Maghfoor
  • Said Y Mohamed
  • Amr Nasser
  • Zubeir Nurgat
  • Syed Zaidi
  • Mohammad Bakr
  • Fahad Al Rabiah
  • Said Yousuf Mohamed
  • Fahad Al Mohareb
  • Fahad Al Sharif
  • Khaled Ibrahim
  • Moosa Patel
  • Hail Al Abdely
  • Walid Rasheed
  • Hazzaa Al Zahrani
  • Shad Ahmed
  • Ghofran Al Qudaihi
  • Said Dermime
  • Hazza Al-Zahrani
  • Abdelghani Tbakhi
  • Khaled Al-Hussein
  • Hazem Ghebeh
  • Fahad Almohareb
  • Fahad Alsharif
  • Abdullah Al-Sulaiman
  • Hamad M Al-Omar
  • Fahad Z Al-Sharif
  • Fayyaz Farooq
  • Ahmed Alami
  • Anja van Biezen
  • Agnes Devergie
  • William Arcese
  • Jaak M Vossen
  • Irene A G Roberts
  • Dietrich Niethammer
  • Ronald Brand
  • Giorgio Dini
  • Simona Iacobelli

Detail Information

Publications15

  1. doi request reprint Status of hematopoietic stem cell transplantation in the WHO Eastern Mediterranean Region (EMRO)
    Mahmoud Aljurf
    King Faisal Cancer Center, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia
    Transfus Apher Sci 42:169-75. 2010
    ..8% of total population has access to such a program in EM region. GNI/capita had no clear association with low HSCT activity; however improvement in infrastructure and establishment of EM regional HSCT registry need prioritization...
  2. doi request reprint High efficacy and low toxicity of APL induction with concurrent idarubicin/ATRA followed by a novel and simplified outpatient post-remission therapy using single doses of idarubicin and intermittent ATRA
    M Aljurf
    King Faisal Cancer Centre, King Faisal Specialist Hospital and Research Centre, P O Box 3354, Riyadh, 11211, Saudi Arabia
    Med Oncol 27:702-7. 2010
    ..6-95.4). The treatment outcome of this program is encouraging; however, the result of this study needs to be validated in larger cohort of patients and optimally in a randomized comparison with other current post-remission approaches...
  3. doi request reprint Standard treatment of acquired SAA in adult patients 18-40 years old with an HLA-identical sibling donor
    M Aljurf
    Adult HSCT Program, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia
    Bone Marrow Transplant 48:178-9. 2013
    ..Early graft failure is rare but potentially life-threatening complication of SCT that can be managed with salvage SCT using more intense conditioning regimen...
  4. pmc Hepatotoxicity induced by horse ATG and reversed by rabbit ATG: a case report
    Khalid A Al-Anazi
    Section of Adult Hematology and Hematopoietic Stem Cell Transplant, King Faisal Cancer Centre, King Faisal Specialist Hospital and Research Centre, P, O, Box 3354, Riyadh 11211, Saudi Arabia
    J Med Case Reports 1:35. 2007
    ..The use of antilymphocyte agents has improved patient and graft survival in hematopoietic stem cell and solid organ transplantation but has been associated with the development of short-term toxicities as well as long-term complications...
  5. ncbi request reprint Successful treatment of steroid-refractory autoimmune thrombocytopenia associated with Castleman disease with anti-CD-20 antibody (rituximab)
    Khalid Ibrahim
    Section of Adult Hematology HSCT, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia
    Hematol Oncol Stem Cell Ther 4:100-2. 2011
    ..Anti-CD20 antibody treatment could be a good therapeutic option for MCD, mainly when associated with immune-related disorders...
  6. pmc Special issues related to hematopoietic SCT in the Eastern Mediterranean region and the first regional activity report
    M D Aljurf
    Adult HSCT, King Faisal Cancer Center, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia
    Bone Marrow Transplant 43:1-12. 2009
    ..27 teams per 10 000 sq km area vs <1-6 teams in Europe). Gross national income per capita had no clear association with low-HSCT activity. Much improvement in infrastructure and formation of an EM regional HSCT registry are needed...
  7. ncbi request reprint Chemotherapy and hematopoietic stem cell transplantation for adult T-cell lymphoblastic lymphoma: current status and controversies
    Mahmoud Aljurf
    Section of Adult Hematology BMT, King Faisal Cancer Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia
    Biol Blood Marrow Transplant 11:739-54. 2005
    ....
  8. ncbi request reprint Antigen- and/or immune-driven lymphoproliferative disorders
    M D Aljurf
    Department of Oncology, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia
    Ann Oncol 14:1595-606. 2003
  9. pmc Autologous bone marrow transplanation for extramedullary plasmacytoma presenting as adrenal incidentaloma
    Mohammed Ahmed
    Departments of Medicine, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia
    Ann Saudi Med 29:219-22. 2009
    ..This case indicates that an EMP should be added to the differential diagnosis of adrenal incidentalomas...
  10. ncbi request reprint High efficacy and low toxicity of short-course oral valganciclovir as pre-emptive therapy for hematopoietic stem cell transplant cytomegalovirus infection
    A J M Saleh
    King Faisal Cancer Centre, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia
    Hematol Oncol Stem Cell Ther 3:116-20. 2010
    ..Valganciclovir (VGC) is a prodrug of ganciclovir with high bioavailability...
  11. ncbi request reprint Emerging role of gammadelta T-cells in health and disease
    Mahmoud Aljurf
    Department of Oncology, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia
    Blood Rev 16:203-6. 2002
    ....
  12. doi request reprint Acquisition of vernal and atopic keratoconjunctivitis after bone marrow transplantation
    Khalid F Tabbara
    Department of Surgery, Division of Ophthalmology, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia
    Am J Ophthalmol 146:462-5. 2008
    ..We present patients who had no history of atopic disorders before bone marrow transplantation (BMT) and who seem to have acquired VKC or AKC from their donors, who had atopic disorders...
  13. doi request reprint Ocular findings after allogeneic hematopoietic stem cell transplantation
    Khalid F Tabbara
    The Eye Center and The Eye Foundation for Research in Ophthalmology, Riyadh, Saudi Arabia
    Ophthalmology 116:1624-9. 2009
    ..To study the incidence, causes, and outcome of major ocular complications in patients undergoing allogeneic hematopoietic stem cell transplantation (HSCT)...
  14. doi request reprint The Wilms' tumor antigen is a novel target for human CD4+ regulatory T cells: implications for immunotherapy
    Cynthia Lehe
    Tumor Immunology Section, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia
    Cancer Res 68:6350-9. 2008
    ..Collectively, our in vitro and in vivo findings strongly suggest important implications for the clinical manipulation of T(regs) in cancer patients...
  15. ncbi request reprint Stem cell transplantation for chronic myeloid leukemia in children
    Kate Cwynarski
    Paediatric and Chronic Leukaemia Working Parties of the European Group for Blood and Marrow Transplantation
    Blood 102:1224-31. 2003
    ..4; 95% CI, 1.36-4.3; P =.003) were significant. This is the first large series to show that SCT confers long-term LFS in most children with CML and helps assess alternative therapy, including tyrosine kinase inhibitors...